Fulgent Genetics is transforming into a healthcare company with a focus on oncology, presenting a promising opportunity. Read ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

NEW YORK – The Alzheimer's Drug Discovery Foundation on Wednesday announced that it has invested $7.0 million in Alzheimer's disease diagnostic company C2N Diagnostics. Already have a 360Dx or ...

Trinity Biotech plc TRIB has announced the acquisition of privately held Irish deep-tech company Metabolomics Diagnostics.

New investment supports DxA's mission to advance the development of scalable and universally accessible diagnostics. Blood ...

Ibex Medical Analytics (Ibex), the leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the findings of its inaugural Patient Insight Report on Cancer Diagnostics. The ...

NEW YORK – Fujirebio said Wednesday that its subsidiary Fujirebio Diagnostics has filed its Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic with the US Food and Drug ...

Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately ...

Professor Julius Lucks’s device leverages advances in in vitro synthetic biology to diagnose disease in crops before the ...

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable ...